Patrick M Sweeney & Associates Inc. Invests $1.08 Million in Haleon plc (NYSE:HLN)

Patrick M Sweeney & Associates Inc. purchased a new stake in Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 131,635 shares of the company's stock, valued at approximately $1,083,000. Haleon accounts for approximately 1.0% of Patrick M Sweeney & Associates Inc.'s investment portfolio, making the stock its 23rd biggest position.

A number of other institutional investors also recently modified their holdings of the business. Financial Advocates Investment Management raised its stake in Haleon by 10.5% in the third quarter. Financial Advocates Investment Management now owns 14,849 shares of the company's stock valued at $124,000 after purchasing an additional 1,408 shares in the last quarter. Blue Barn Wealth LLC lifted its holdings in shares of Haleon by 7.3% during the 4th quarter. Blue Barn Wealth LLC now owns 20,858 shares of the company's stock worth $172,000 after acquiring an additional 1,425 shares during the period. Portside Wealth Group LLC boosted its position in shares of Haleon by 6.0% during the 3rd quarter. Portside Wealth Group LLC now owns 27,445 shares of the company's stock worth $229,000 after acquiring an additional 1,564 shares in the last quarter. Wright Investors Service Inc. increased its stake in Haleon by 16.2% in the third quarter. Wright Investors Service Inc. now owns 12,905 shares of the company's stock valued at $107,000 after acquiring an additional 1,803 shares during the last quarter. Finally, Baker Tilly Wealth Management LLC lifted its stake in Haleon by 6.1% during the fourth quarter. Baker Tilly Wealth Management LLC now owns 32,989 shares of the company's stock worth $271,000 after purchasing an additional 1,905 shares during the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Price Performance

Shares of NYSE:HLN traded down $0.14 during trading on Wednesday, hitting $8.19. 7,062,765 shares of the company were exchanged, compared to its average volume of 5,499,876. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. Haleon plc has a 1-year low of $7.70 and a 1-year high of $8.98. The company has a market capitalization of $37.40 billion, a P/E ratio of 27.30, a price-to-earnings-growth ratio of 2.19 and a beta of 0.28. The business's 50 day moving average is $8.34 and its 200-day moving average is $8.29.

Haleon Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be given a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon's dividend payout ratio is presently 70.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HLN shares. HSBC started coverage on Haleon in a research note on Wednesday, April 17th. They issued a "buy" rating on the stock. Argus reissued a "buy" rating on shares of Haleon in a report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy".

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.